GOEL DAVID E. 4
4 · Adaptive Biotechnologies Corp · Filed Feb 17, 2021
Insider Transaction Report
Form 4
GOEL DAVID E.
Director10% OwnerOther
Transactions
- Award
Stock Option (Right to Buy)
2021-02-15+3,759→ 3,759 totalExercise: $66.50Exp: 2031-02-15→ Common Stock (3,759 underlying) - Award
Common Stock
2021-02-15+1,504→ 1,504 total
Footnotes (2)
- [F1]The filing of this statement shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. The Reporting Person expressly disclaims beneficial ownership of the securities reported herein except to the extent of his pecuniary interest therein.
- [F2]The option will vest in equal monthly installments over one year, subject to continued service as a director through such vesting date.